Annual Total Liabilities
$96.25 M
+$60.40 M+168.49%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual total liabilities is currently $96.25 million, with the most recent change of +$60.40 million (+168.49%) on 31 December 2023. During the last 3 years, it has risen by +$77.18 million (+404.68%). CRNX annual total liabilities is now at all-time high.CRNX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$104.39 M
-$378.00 K-0.36%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly total liabilities is currently $104.39 million, with the most recent change of -$378.00 thousand (-0.36%) on 30 September 2024. Over the past year, it has increased by +$8.15 million (+8.46%). CRNX quarterly total liabilities is now -0.36% below its all-time high of $104.77 million, reached on 30 June 2024.CRNX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.5% |
| 3 y3 years | +404.7% | +447.4% |
| 5 y5 years | +627.0% | +688.6% |
CRNX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +404.7% | -0.4% | +447.4% |
| 5 y | 5 years | at high | +627.0% | -0.4% | +697.2% |
| alltime | all time | at high | +760.1% | -0.4% | +1039.7% |
Crinetics Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $104.39 M(-0.4%) |
| June 2024 | - | $104.77 M(+1.5%) |
| Mar 2024 | - | $103.22 M(+7.2%) |
| Dec 2023 | $96.25 M(+168.5%) | $96.25 M(+2.6%) |
| Sept 2023 | - | $93.79 M(+139.6%) |
| June 2023 | - | $39.14 M(+16.2%) |
| Mar 2023 | - | $33.68 M(-6.1%) |
| Dec 2022 | $35.85 M(+88.0%) | $35.85 M(+7.0%) |
| Sept 2022 | - | $33.51 M(-5.8%) |
| June 2022 | - | $35.57 M(+17.6%) |
| Mar 2022 | - | $30.24 M(+58.6%) |
| Dec 2021 | $19.07 M | $19.07 M(+20.9%) |
| Sept 2021 | - | $15.77 M(+1.8%) |
| June 2021 | - | $15.49 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $14.07 M(-3.1%) |
| Dec 2020 | $14.53 M(+9.7%) | $14.53 M(+10.9%) |
| Sept 2020 | - | $13.10 M(-8.7%) |
| June 2020 | - | $14.35 M(-7.1%) |
| Mar 2020 | - | $15.45 M(+16.7%) |
| Dec 2019 | $13.24 M(+18.3%) | $13.24 M(+1.9%) |
| Sept 2019 | - | $12.99 M(-0.5%) |
| June 2019 | - | $13.05 M(-9.2%) |
| Mar 2019 | - | $14.37 M(+28.4%) |
| Dec 2018 | $11.19 M(-63.5%) | $11.19 M(+22.2%) |
| Sept 2018 | - | $9.16 M(-90.8%) |
| June 2018 | - | $99.88 M(+3.7%) |
| Mar 2018 | - | $96.31 M(+214.5%) |
| Dec 2017 | $30.62 M(+62.8%) | $30.62 M |
| Dec 2016 | $18.80 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly total liabilities year-on-year change?
What is Crinetics Pharmaceuticals annual total liabilities?
The current annual total liabilities of CRNX is $96.25 M
What is the all time high annual total liabilities for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual total liabilities is $96.25 M
What is Crinetics Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CRNX is $104.39 M
What is the all time high quarterly total liabilities for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly total liabilities is $104.77 M
What is Crinetics Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, CRNX quarterly total liabilities has changed by +$8.15 M (+8.46%)